Jun 6, 2019 | Press & Recognition
‘En Solucion, Inc., Austin, Texas, received a $25,000 cash prize and Future Food Disruptor of the Year award. The company was founded “to develop technology that can keep healthy food healthy,” said Kenton Harmer, c.e.o. of En Solucion.’ Start-ups awarded...
Apr 13, 2019 | Press & Recognition
‘Celling Biosciences (“Celling”), based in Austin, Texas, acquired all the assets and stock of ThermiGen, the aesthetic device division of Spanish pharmaceutical leader Almirall. ThermiGen, founded in Dallas in 2012, commercializes a unique line of...
Feb 5, 2019 | Press & Recognition
‘Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary indications, announced today the hiring of Charles T. Garner as Chief Financial Officer and the appointment of R.A. Session, II, to the...
Jan 22, 2019 | Press & Recognition
‘Co-founded by CEO Monica Berrondo and CTO Susana Kaufmann, this women-led company is set on revolutionizing antibody design. Macromoltek was initiated in 2010 with the aim of improving antibody drug development with the use of proprietary algorithms,...
Oct 29, 2018 | Press & Recognition
En Solución was awarded a 2018 Phase I SBIR grant from the FDA to pursue its research and development. They have joined ACC Bioscience Incubator to improve food safety through development of novel methods for cleaning and sanitizing. Learn more about the company...